ELIXIR launches as legal entity


New Picture (1)
New Picture (1)On 18 December 2013, ELIXIR enters its permanent phase as Estonia becomes the fifth country to ratify the ELIXIR Consortium Agreement. This marks the formal launch of the infrastructure for biological data in Europe, supporting life science research and its translation to medicine, the bioindustries and society.

New Picture (1)

ELIXIR today becomes an independent legal entity as Estonia joins the United Kingdom, Sweden, Switzerland, the Czech Republic and the European Molecular Biology Laboratory (EMBL) in ratifying the ELIXIR Consortium Agreement. ELIXIR aims to maximize the impact of big data in medicine, agriculture and the environment through the creation of a sustainable data infrastructure.

The ELIXIR Memorandum of Understanding has been signed by EMBL and 17 countries, including Belgium, Czech Republic, Denmark, Estonia, Finland, France, Greece, Israel, Italy, the Netherlands, Norway, Portugal, Slovenia, Spain, Sweden, Switzerland and the United Kingdom.

At the launch of ELIXIR, prominent policy makers and scientists from ELIXIR member states and the European Commission underscore the importance of this research infrastructure to the future of Europe’s life science sector.

The ELIXIR NL node is hosted by DTL.

Read more

Leave a Reply

Your email address will not be published. Required fields are marked *